CRBP Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.00%

Insider Buying (Last 12 Months): $7,003,500.00

Insider Selling (Last 12 Months): $2,530,798.76

Corbus Pharmaceuticals Insider Trading History Chart

Corbus Pharmaceuticals Share Price & Price History

^$5.02

▲ +0.1 (2.03%)

As of 04/4/2025 05:00 PM ET

Days: 30 | 90 | 365

Corbus Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/20/2024	Cormorant Asset Management, Lp	Major Shareholder	Buy	350,000	$20.01	$7,003,500.00	2,375,000
6/18/2024	Sean F Moran	CFO	Sell	1,958	$42.12	$82,470.96	48,605
6/17/2024	Yuval Cohen	CEO	Sell	11,103	$46.02	$510,960.06	84,400
6/14/2024	Sean F Moran	CFO	Sell	9,355	$49.87	$466,533.85	48,605
6/14/2024	Yuval Cohen	CEO	Sell	29,317	$50.17	$1,470,833.89	84,400
3/7/2024	Cormorant Asset Management, Lp	Major Shareholder	Buy	250,000	$40.05	$10,012,500.00	1,725,000
2/2/2024	Cormorant Asset Management, Lp	Major Shareholder	Buy	750,000	$19.00	$14,250,000.00	1,475,000
1/26/2024	Cormorant Asset Management, Lp	Major Shareholder	Buy	282,632	$32.24	$9,112,055.68	725,000
8/10/2022	Craig Stuart Millian	COO	Buy	5,000	$0.25	$1,250.00	27,000
8/10/2022	Sean F Moran	CFO	Buy	20,000	$0.26	$5,200.00	199,272
8/10/2022	Yuval Cohen	CEO	Buy	3,800	$0.26	$988.00	98,230
5/16/2022	Sean F Moran	CFO	Buy	12,000	$0.30	$3,600.00	179,272
5/16/2022	Yuval Cohen	CEO	Buy	10,500	$0.25	$2,625.00	94,430

See Full Table

SEC Filings (Institutional Ownership Changes) for Corbus Pharmaceuticals (NASDAQ:CRBP)

64.64% of Corbus Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Corbus Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/17/2025	Velan Capital Investment Management LP	56,700	$0.67M	0.6%	+13.4%	0.466%
2/17/2025	Wexford Capital LP	45,021	$0.53M	0.1%	-34.3%	0.370%
2/17/2025	Two Sigma Advisers LP	11,027	$0.13M	0.0%	N/A	0.091%
2/17/2025	Two Sigma Investments LP	134,175	$1.58M	0.0%	+212.3%	1.102%
2/17/2025	Tang Capital Management LLC	242,653	$2.86M	0.2%	-59.6%	1.992%
2/17/2025	Prosight Management LP	270,000	$3.19M	0.9%	+107.7%	2.217%
2/17/2025	Nuveen Asset Management LLC	28,938	$0.34M	0.0%	-77.8%	0.238%
2/17/2025	Orbimed Advisors LLC	1,172,287	$13.83M	0.3%	+28.5%	9.625%
2/17/2025	Millennium Management LLC	386,653	$4.56M	0.0%	+215.0%	3.174%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	162,962	$1.92M	0.0%	-5.6%	1.338%
2/17/2025	Deutsche Bank AG	8,206	$97K	0.0%	+46.8%	0.067%
2/17/2025	Bank of America Corp DE	31,475	$0.37M	0.0%	+29.7%	0.258%
2/17/2025	BNP Paribas Financial Markets	27,383	$0.32M	0.0%	N/A	0.225%
2/14/2025	Northern Trust Corp	103,264	$1.22M	0.0%	+12.4%	0.848%
2/14/2025	Aquatic Capital Management LLC	8,555	$0.10M	0.0%	N/A	0.070%
2/14/2025	Boothbay Fund Management LLC	10,534	$0.12M	0.0%	-75.5%	0.086%
2/14/2025	Price T Rowe Associates Inc. MD	164,735	$1.95M	0.0%	-49.4%	1.353%
2/14/2025	Tower Research Capital LLC TRC	4,726	$56K	0.0%	-63.2%	0.039%
2/14/2025	Altium Capital Management LLC	385,000	$4.54M	1.3%	+97.4%	3.161%
2/13/2025	Jump Financial LLC	28,709	$0.34M	0.0%	N/A	0.236%
2/13/2025	Walleye Capital LLC	55,236	$0.65M	0.0%	+49.4%	0.453%
2/13/2025	Barclays PLC	18,156	$0.22M	0.0%	-85.3%	0.149%
2/13/2025	Renaissance Technologies LLC	139,100	$1.64M	0.0%	+769.4%	1.142%
2/13/2025	Wells Fargo & Company MN	6,444	$76K	0.0%	+51.7%	0.053%
2/12/2025	Geode Capital Management LLC	263,532	$3.11M	0.0%	+5.5%	2.164%
2/6/2025	Charles Schwab Investment Management Inc.	97,882	$1.16M	0.0%	+4.5%	0.804%
2/4/2025	Bank of New York Mellon Corp	23,207	$0.27M	0.0%	-4.4%	0.191%
2/4/2025	HealthInvest Partners AB	98,304	$1.19M	0.6%	+41.3%	0.807%
1/15/2025	Avanza Fonder AB	7,150	$84K	0.0%	N/A	0.059%
12/26/2024	JPMorgan Chase & Co.	5,507	$0.11M	0.0%	+27.0%	0.045%
11/16/2024	Geode Capital Management LLC	249,759	$5.15M	0.0%	+8.1%	2.051%
11/15/2024	Vestcor Inc	3,100	$64K	0.0%	N/A	0.025%
11/15/2024	Y Intercept Hong Kong Ltd	18,372	$0.38M	0.0%	N/A	0.151%
11/15/2024	Wellington Management Group LLP	23,801	$0.49M	0.0%	N/A	0.195%
11/15/2024	Wexford Capital LP	68,556	$1.41M	0.3%	+55.3%	0.563%
11/15/2024	State Street Corp	595,576	$12.29M	0.0%	+34.6%	4.890%
11/15/2024	HighVista Strategies LLC	75,292	$1.55M	0.5%	+94.1%	0.618%
11/14/2024	Walleye Capital LLC	36,963	$0.76M	0.0%	-75.4%	0.303%
11/14/2024	Acuta Capital Partners LLC	18,500	$0.38M	0.3%	-71.3%	0.152%
11/14/2024	MetLife Investment Management LLC	5,951	$0.12M	0.0%	N/A	0.049%
11/13/2024	FMR LLC	10,028	$0.21M	0.0%	+33.0%	0.082%
11/13/2024	The Manufacturers Life Insurance Company	22,731	$0.47M	0.0%	+7.6%	0.187%
11/12/2024	Charles Schwab Investment Management Inc.	93,643	$1.93M	0.0%	+224.7%	0.778%
11/12/2024	HealthInvest Partners AB	69,573	$1.44M	0.7%	+77.9%	0.578%
11/5/2024	Victory Capital Management Inc.	24,760	$0.51M	0.0%	+29.9%	0.206%
10/25/2024	abrdn plc	26,894	$0.56M	0.0%	+422.9%	0.252%
10/23/2024	Assenagon Asset Management S.A.	221,184	$4.56M	0.0%	-7.4%	2.070%
10/3/2024	SG Americas Securities LLC	7,331	$0.15M	0.0%	N/A	0.069%
8/19/2024	Point72 Asset Management L.P.	216,515	$9.80M	0.0%	-69.1%	2.026%
8/15/2024	The Manufacturers Life Insurance Company	21,131	$0.96M	0.0%	+100.7%	0.198%
8/15/2024	Millennium Management LLC	241,649	$10.94M	0.0%	-25.6%	2.261%
8/15/2024	Darwin Global Management Ltd.	325,140	$14.27M	1.7%	N/A	3.042%
8/14/2024	Integral Health Asset Management LLC	100,000	$4.53M	0.4%	N/A	0.936%
8/14/2024	HighVista Strategies LLC	38,793	$1.76M	0.6%	N/A	0.363%
8/13/2024	Ensign Peak Advisors Inc	45,364	$2.05M	0.0%	-32.8%	0.424%
8/7/2024	ClariVest Asset Management LLC	16,021	$0.73M	0.1%	N/A	0.150%
8/6/2024	Acadian Asset Management LLC	15,854	$0.72M	0.0%	N/A	0.148%
8/5/2024	Victory Capital Management Inc.	19,060	$0.86M	0.0%	N/A	0.178%
8/3/2024	TD Asset Management Inc	40,800	$1.85M	0.0%	+92.5%	0.382%
8/1/2024	Rhumbline Advisers	14,103	$0.64M	0.0%	N/A	0.132%
7/26/2024	Bank of New York Mellon Corp	30,236	$1.37M	0.0%	N/A	0.283%
7/18/2024	Assenagon Asset Management S.A.	238,759	$10.80M	0.0%	-8.0%	2.233%
5/17/2024	Ikarian Capital LLC	559,271	$21.95M	2.4%	+185.5%	5.232%
5/16/2024	Janus Henderson Group PLC	339,074	$13.36M	0.0%	N/A	3.172%
5/15/2024	Price T Rowe Associates Inc. MD	192,495	$7.55M	0.0%	N/A	1.801%
5/15/2024	Altitude Crest Partners Inc.	103,703	$4.07M	1.7%	N/A	0.970%
5/10/2024	Vanguard Group Inc.	437,264	$17.16M	0.0%	+143.7%	4.162%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	24,880	$0.98M	0.0%	N/A	0.237%
4/24/2024	Assenagon Asset Management S.A.	259,456	$10.18M	0.0%	N/A	2.469%
5/15/2023	Sio Capital Management LLC	150,000	$1.09M	0.5%	N/A	3.559%
5/10/2023	Tekla Capital Management LLC	5,143	$37K	0.0%	-96.7%	0.122%
5/1/2023	Virtu Financial LLC	10,077	$73K	0.0%	N/A	0.239%
1/25/2023	Pinnacle Associates Ltd.	731,350	$84K	0.0%	-11.6%	0.584%
11/15/2022	ETF Managers Group LLC	4,710,319	$0.78M	0.0%	-33.3%	3.760%
11/10/2022	ExodusPoint Capital Management LP	362,544	$60K	0.0%	N/A	0.289%
11/1/2022	Pinnacle Associates Ltd.	827,240	$0.14M	0.0%	-9.1%	0.660%
8/12/2022	Ikarian Capital LLC	862,527	$0.22M	0.0%	-13.5%	0.689%
7/26/2022	Mirae Asset Global Investments Co. Ltd.	4,029,171	$1.02M	0.0%	+7.3%	3.217%
6/2/2022	Mirae Asset Global Investments Co. Ltd.	3,754,954	$2M	0.0%	-7.7%	2.998%
5/11/2022	GSA Capital Partners LLP	517,806	$0.28M	0.0%	N/A	0.413%
5/10/2022	Mirae Asset Global Investments Co. Ltd.	3,754,954	$2M	0.0%	-7.7%	2.998%
5/5/2022	Pinnacle Associates Ltd.	914,887	$0.49M	0.0%	-3.4%	0.731%
4/28/2022	Davy Global Fund Management Ltd	435,285	$0.23M	0.0%	+36.6%	0.348%
2/14/2022	ETF Managers Group LLC	14,138,998	$8.53M	0.2%	+0.3%	11.290%
2/10/2022	Acadian Asset Management LLC	184,026	$0.11M	0.0%	N/A	0.147%
2/8/2022	Mirae Asset Global Investments Co. Ltd.	4,070,006	$2.51M	0.0%	+1.7%	3.250%
2/3/2022	Cambridge Investment Research Advisors Inc.	115,919	$71K	0.0%	+27.5%	0.093%
2/2/2022	Davy Global Fund Management Ltd	318,668	$0.20M	0.0%	+10.0%	0.254%
1/18/2022	Aries Wealth Management	107,800	$66K	0.0%	+360.7%	0.086%
1/14/2022	Spire Wealth Management	45,000	$28K	0.0%	N/A	0.036%
11/15/2021	Penserra Capital Management LLC	434,874	$0.44M	0.0%	+19.2%	0.347%
11/12/2021	Geode Capital Management LLC	1,386,108	$1.41M	0.0%	+2.1%	1.107%
11/12/2021	Vident Investment Advisory LLC	147,113	$0.15M	0.0%	N/A	0.117%
11/9/2021	BlackRock Inc.	2,566,443	$2.62M	0.0%	+8.7%	2.049%
10/27/2021	Davy Global Fund Management Ltd	289,627	$0.30M	0.0%	-90.0%	0.231%
10/19/2021	Pinnacle Associates Ltd.	966,014	$0.99M	0.0%	-3.2%	0.771%
9/17/2021	Virtu Financial LLC	85,031	$0.16M	0.0%	-44.3%	0.068%
9/3/2021	Parametric Portfolio Associates LLC	61,837	$0.11M	0.0%	+126.8%	0.049%
8/26/2021	Y Intercept Hong Kong Ltd	20,467	$37K	0.0%	N/A	0.016%
8/17/2021	Walleye Capital LLC	168,824	$0.31M	0.0%	N/A	0.135%

Data available starting January 2016

See Full Table

Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, develops products to defeat serious illness. It develops CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E (MMAE), which is in Phase I clinical trial; CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells for the treatment of solid tumors; CRB-913, a peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, including the Jenrin library of approximately 600 compounds, and multiple issued and pending patent filings. The company was incorporated in 2009 and is based in Norwood, Massachusetts.

Today's Range

Now: $5.02

$4.68

$5.04

50 Day Range

MA: $7.69

$4.92

$11.33

52 Week Range

Now: $5.02

$4.67

$61.90

Volume

204,551 shs

Average Volume

365,758 shs

Market Capitalization

$61.40 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

3.12

Who are the company insiders with the largest holdings of Corbus Pharmaceuticals?: Corbus Pharmaceuticals' top insider shareholders include:
Cormorant Asset Management, Lp (Major Shareholder)
Yuval Cohen (CEO)
Sean F Moran (CFO)
Learn More about top insider investors at Corbus Pharmaceuticals.